Cultural determinants of infection control behaviour: Understanding drivers and implementing effective change

Journal of Hospital Infection

Volumn 86, Issue 3, 2014, Pages 161-168

  Borg, M A ^a  

^a MATER DEI HOSPITAL   (Malta)

Author keywords

Behaviour change; Empowerment; Hofstede; Professional culture

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BEHAVIOR CHANGE; CULTURAL VALUE; EMPOWERMENT; EUROPE; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INCIDENCE; INDIVIDUALITY; INFECTION CONTROL; INFECTION PREVENTION; MASCULINITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT SAFETY; PREVALENCE; SHORT SURVEY; ARTICLE; ATTITUDE TO HEALTH; BEHAVIOR; CROSS INFECTION; CULTURAL ANTHROPOLOGY; HEALTH PERSONNEL ATTITUDE; HOFSTEDE; PRACTICE GUIDELINE; PROFESSIONAL COMPETENCE; PROFESSIONAL CULTURE;

BEHAVIOUR CHANGE; EMPOWERMENT; HOFSTEDE; PROFESSIONAL CULTURE;

ATTITUDE OF HEALTH PERSONNEL; CROSS INFECTION; CULTURE; EUROPE; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFECTION CONTROL; POWER (PSYCHOLOGY); PROFESSIONAL COMPETENCE;

EID: 84895895964     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2013.12.006     Document Type: Short Survey

References (42)

1. Seto W.H. Staff compliance with infection control practices: application of behavioural sciences. JHosp Infect 1995, 30:S107-S115.
2. Cars O., Mölstad S., Melander A. Variation in antibiotic use in the European Union. Lancet 2001, 9:1851-1853.
3. Surveillance of antimicrobial consumption in Europe, 2010 2013, European Centre for Disease Prevention and Control, ECDC, Stockholm.
4. Grigoryan L., Haaijer-Ruskamp F., Burgerhof J.G., et al. Self-medication with antimicrobial drugs in Europe. Emerg Infect Dis 2006, 12:452-459.
5. Borg M.A. National cultural dimensions as drivers of inappropriate ambulatory care consumption of antibiotics in Europe and their relevance to awareness campaigns. JAntimicrob Chemother 2012, 67:763-767.
6. Point prevalence survey of healthcare associated infections and antimicrobial use in European acute care hospitals 2013, European Centre for Disease Prevention and Control, ECDC, Stockholm.
7. Johnson A.P. Methicillin-resistant Staphylococcus aureus: the European landscape. JAntimicrob Chemother 2011, 66:iv43-iv48.
8. Antimicrobial resistance surveillance in Europe 2012. Annual report of the European Antimicrobial Resistance Surveillance Network (EARSNet) 2013, European Centre for Disease Prevention and Control, ECDC, Stockholm.
9. Duerden B.I. Responsibility for managing healthcare-associated infections: where does the buck stop?. JHosp Infect 2009, 73:414-417.
10. Hansen S., Schwab F., Asensio A., et al. Methicillin-resistant Staphylococcus aureus (MRSA) in Europe: which infection control measures are taken?. Infection 2010, 38:159-164.
11. MacKenzie F.M., Bruce J., Struelens M.J., et al. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals. Clin Microbiol Infect 2007, 13:269-276.
12. Goossens H. Expert-proposed European strategies to monitor and control infection, antibiotic use, and resistance in health-care facilities. Lancet Infect Dis 2011, 11:338-340.
13. Hofstede G., Hofstede G.J., Minkov M. Cultures and organisations: software of the mind 2010, McGraw-Hill, New York.
14. Deschepper R., Grigoryan L., Lundborg C.S., et al. Are cultural dimensions relevant for explaining cross-national differences in antibiotic use in Europe?. BMC Health Serv Res 2008, 8:123.
15. Borg M.A., Camilleri L., Waisfisz B. Understanding the epidemiology of MRSA in Europe: do we need to think outside the box?. JHosp Infect 2012, 81:251-256.
16. Borg M.A. Prolonged perioperative surgical prophylaxis within European hospitals: an exercise in uncertainty avoidance?. JAntimicrob Chemother 2013 Nov 13, [Epub ahead of print].
17. Elliot P. Infection control: a psychosocial approach to changing practice 2009, Radcliffe, Oxford.
18. Nicol P.W., Watkins R.E., Donovan R.J., Wynaden D., Cadwallader H. The power of vivid experience in hand hygiene compliance. JHosp Infect 2009, 72:36-42.
19. Hofstede G. Culture's consequences: comparing values, behaviors, institutions, and organizations across nations 2001, Sage Publications, Thousand Oaks, CA.
20. Meyer E., Gastmeier P., Schwab F. National MRSA rates run along with fair play of national football teams: a cross-national data analysis of the European Football Championship, 2008. Infection 2013, 41:215-218.
21. Borg M.A. Are healthcare economics a factor behind European MRSA rates?. Eur J Clin Microbiol Infect Dis 2010, 29:477-479.
22. Borg M.A. Could the incidence of healthcare infections in Europe simply be a reflection of overall quality standards?. JHosp Infect 2012, 82:141-142.
23. Liebowitz L.D. MRSA burden and interventions. Int J Antimicrob Agents 2009, 34:S11-S13.
24. Duerden B.I. MRSA: why have we got it and can we do anything about it?. Eye (Lond) 2012, 26:218-221.
25. Wilson J., Guy R., Elgohari S., et al. Trends in sources of meticillin resistant Staphylococcus aureus (MRSA) bacteraemia: data from the national mandatory surveillance of MRSA bacteraemia in England, 2006-2009. JHosp Infect 2011, 79:211-217.
26. Jarlier V., Trystram D., Brun-Buisson C., et al. Curbing methicillin resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Archs Intern Med 2010, 170:552-559.
27. Magiorakos A.P., Leens E., Drouvot V., et al. Pathways to clean hands: highlights of successful hand hygiene implementation strategies in Europe. Euro Surveill 2010, 15:19560.
28. Pittet D. The Lowbury Lecture: behaviour in infection control. JHosp Infect 2004, 58:1-13.
29. Formoso G., Liberati A., Magrini N. Practice guidelines: useful and "participative" method? Survey of Italian physicians by professional setting. Archs Intern Med 2001, 161:2037-2042.
30. Seto W.H., Ching T.Y., Chu Y.B., Seto W.L. Social power and motivation for the compliance of nurses and housekeeping staff with infection control policies. Am J Infect Control 1991, 19:42-44.
31. Mintzberg H. The structuring of organizations 1979, Prentice-Hall, Englewood Cliffs.
32. Haley R.W., Culver D.H., White J.W., et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985, 121:182-205.
33. Jarvis W.R. The Lowbury Lecture. The United States approach to strategies in the battle against healthcare-associated infections, 2006: transitioning from benchmarking to zero tolerance and clinician accountability. JHosp Infect 2007, S2:3-9.
34. Berenholtz S.M., Pronovost P.J., Lipsett P.A., et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004, 32:2014-2020.
35. McGuckin M., Govednik J. Patient empowerment and hand hygiene, 1997-2012. JHosp Infect 2013, 84:191-199.
36. WHO guidelines on hand hygiene in health care 2009, World Health Organization, WHO, Geneva.
37. Edwards R., Charani E., Sevdalis N., et al. Optimisation of infection prevention and control in acute health care by use of behaviour change: a systematic review. Lancet Infect Dis 2012, 12:318-329.
38. Gould D.J., Hewitt-Taylor J., Drey N.S., Gammon J., Chudleigh J., Weinberg J.R. The CleanYourHandsCampaign: critiquing policy and evidence base. JHosp Infect 2007, 65:95-101.
39. Harbarth H., Samore M.H. Antimicrobial resistance determinants and future control. Emerg Infect Dis 2005, 11:794-801.
40. Jung T., Scott T., Davies H., et al. Instruments for exploring organizational culture: a review of the literature. Public Admin Rev 2009, 69:1087-1096.
41. Payer L. Medicine and culture 1996, Holt, New York.
42. De Bono S., Heling G., Borg M.A. Organizational culture and its implications for infection prevention and control in healthcare institutions. JHosp Infect 2014, 86:1-4.